Literature DB >> 9016835

On the synthesis of neurotransmitter receptor agonists with antagonist potential.

D S Crumrine1, M D Choubal, J R Kanofsky, J J Feigenbaum.   

Abstract

The synthesis of a new type of antagonist is described, capable of inactivating neuroreceptors with heretofore unattainable selectivity and permanence. These antagonists are referred to as mazek agonists (i.e. direct, inhibitory agonists) as they have the high receptor affinity and initial receptor-stimulatory effect of direct agonists and are positively coupled to effector systems. However, like direct antagonists, they have a high receptor affinity and the potential to inhibit or prevent receptor stimulation. The synthesis of the present compounds consisted of the covalent attachment of a tethered dye to three different neurotransmitter analogues, resulting in dye-neuropeptide conjugates with a high affinity for the FMRFa receptor. The dye was prepared from azure B (Az), the neurotransmitter was the neuropeptide FMRFamide (FMRFa), and the dye-neuropeptide conjugates synthesized were Az-CFMRFa; Az-CFMRF and Az-CLRFa. In this procedure, the analogues serve as carrier molecules, bound at one end to the receptor and at the other end to the dye, which is thereby brought into close contact with the receptor. The receptor can then be inactivated by singlet oxygen generated by laser irradiation of the photosensitized receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016835     DOI: 10.1023/a:1027399003778

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  10 in total

Review 1.  A brief survey of methods for preparing protein conjugates with dyes, haptens, and cross-linking reagents.

Authors:  M Brinkley
Journal:  Bioconjug Chem       Date:  1992 Jan-Feb       Impact factor: 4.774

2.  Rapid killing of single neurons by irradiation of intracellularly injected dye.

Authors:  J P Miller; A Selverston
Journal:  Science       Date:  1979-11-09       Impact factor: 47.728

3.  Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors.

Authors:  J Costentin; H Marçais; P Protais; M Baudry; S De La Baume; M P Martres; J C Schwartz
Journal:  Life Sci       Date:  1977-08-01       Impact factor: 5.037

4.  Receptor inactivation by dye-neuropeptide conjugates: 1. The synthesis of Cys-containing dye-neuropeptide conjugates.

Authors:  J J Feigenbaum; M D Choubal; K Payza; J R Kanofsky; D S Crumrine
Journal:  Peptides       Date:  1996       Impact factor: 3.750

5.  Advantages of preelectrophoretic conjugation of polypeptides with fluorescent dyes.

Authors:  J M Strottmann; J B Robinson; E Stellwagen
Journal:  Anal Biochem       Date:  1983-07-15       Impact factor: 3.365

6.  Dye-sensitized photodynamic inactivation of cells.

Authors:  J P Pooler; D P Valenzeno
Journal:  Med Phys       Date:  1981 Sep-Oct       Impact factor: 4.071

7.  New Method to Prepare N-t-Butoxycarbonyl Derivatives and the Corresponding Sulfur Analogs from di-t-Butyl Dicarbonate or di-t-Butyl Dithiol Dicarbonates and Amino Acids.

Authors:  D S Tarbell; Y Yamamoto; B M Pope
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

8.  Receptor inactivation by dye-neuropeptide conjugates. 3. Comparative binding of dye-neuropeptide conjugates to FMRFamide receptors of Helix aspersa and Loligo pealei.

Authors:  J J Feigenbaum; M D Choubal; D S Crumrine; J R Kanofsky; K Payza
Journal:  Peptides       Date:  1996       Impact factor: 3.750

9.  Receptor inactivation by dye-neuropeptide conjugates: 2. Characterization of the quantum yield of singlet oxygen generated by irradiation of dye-neuropeptide conjugates.

Authors:  J J Feigenbaum; M D Choubal; D S Crumrine; J R Kanofsky
Journal:  Peptides       Date:  1996       Impact factor: 3.750

10.  Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.

Authors:  T A Pugsley; C L Christofferson; A Corbin; H A DeWald; S Demattos; L T Meltzer; S L Myers; Y H Shih; S Z Whetzel; J N Wiley
Journal:  J Pharmacol Exp Ther       Date:  1992-12       Impact factor: 4.030

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.